drugset / Trial / NCT07605806
Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions
Phase 1/2
Recruiting
25 enrolled
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID) · collab
NaSingle-groupOpen-labelOther
Summary
The goal of this clinical trial is to investigate biomarkers of non-IgE-mediated immediate hypersensitivity reactions during infusion of intravenous vancomycin. The main question it aims to answer is: • Identifying novel biomarkers in blood that occur during infusion reaction Participants will: * Have allergy skin testing for vancomycin * Receive an infusion of vancomycin
Timeline
- Start
- 2026-05-21
- Primary completion
- 2027-05-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vancomycin | Other / unclassified | — | Intravenous |